Susquehanna International Group, LLP Vanda Pharmaceuticals Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $608,981 - $837,514	-132,100 Reduced 91.36%	12,500 $58,000
Q2 2024 Aug 15, 2024	BUY	$3.91 - $6.5 $303,807 - $505,050	77,700 Added 116.14%	144,600 $816,000
Q1 2024 May 07, 2024	BUY	$3.47 - $4.61 $232,143 - $308,409	66,900 New	66,900 $274,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $45,796 - $70,299	10,700 New	10,700 $46,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $118,851 - $189,608	17,300 Added 87.37%	37,100 $274,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $90,624 - $112,896	9,600 Added 94.12%	19,800 $196,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.